Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Herceptin|DRUG: Taxol|DRUG: Fluorouracil|DRUG: Cytoxan|DRUG: Epirubicin
Sponsor: M.D. Anderson Cancer Center
Collaborators: Genentech, Inc.